# Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients

> **NCT01427907** · PHASE4 · COMPLETED · sponsor: **Fresenius Medical Care North America** · enrollment: 38 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Calcium acetate oral solution (COS)
- **DRUG:** Sevelamer carbonate

## Key facts

- **NCT ID:** NCT01427907
- **Lead sponsor:** Fresenius Medical Care North America
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2016-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01427907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01427907, "Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01427907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*